Skip to main content
Marshall Posner, MD, Oncology, New York, NY, The Mount Sinai Hospital

MarshallRPosnerMD

Oncology New York, NY

Head & Neck Cancer

Professor of Medicine, Icahn School of Medicine at Mount Sinai; Medical Director, Head and Neck Oncology; co-Director Cancer Clinical Investigation Program, Tisch Cancer Institute

Dr. Posner is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Posner's full profile

Already have an account?

Summary

  • Dr. Marshall Posner is an oncologist in New York, NY and is a professor of medicine at Mount Sinai Hospital. He received his BA from Yale University and his medical degree from Tufts University School of Medicine and has been in practice 40+ years. He specializes in clinical trials, immunotherapy, and head and neck oncology. He is medical Director of the Head and Neck Oncology Program at Mount Sinai and co-director of the Cancer Clinical Investigation Program for the Tisch Caner Institute. He has over 250 peer reviewed publications and numerous patents.

Education & Training

  • Dana-Farber Cancer InstituteFellowship, Medical Oncology, 1978 - 1981
  • Boston University Medical Center
    Boston University Medical CenterResidency, Internal Medicine, 1975 - 1978
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 1975

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2020 - Present
  • NY State Medical License
    NY State Medical License 2010 - 2022
  • RI State Medical License
    RI State Medical License 1983 - 1992
  • MA State Medical License
    MA State Medical License 1978 - 2019
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Top Doctors: New York Metro Area Castle Connolly, 2011-2014
  • America's Top Doctors Castle Connolly, 2009-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Gp41-Targeted Antibodies Restore Infectivity of a Fusion-Deficient HIV-1 Envelope Glycoprotein
    Gp41-Targeted Antibodies Restore Infectivity of a Fusion-Deficient HIV-1 Envelope GlycoproteinMay 11th, 2020
  • Study: Anal Cancer, and Mortality Rates from the Disease, Have Increased -- What's Going on? | SurvivorNet
    Study: Anal Cancer, and Mortality Rates from the Disease, Have Increased -- What's Going on? | SurvivorNetNovember 20th, 2019
  • Marcia Cross Had Anal Cancer Tied to HPV, but Still Hesitated to Vaccinate Her Young Daughters. Here's Why She Did It
    Marcia Cross Had Anal Cancer Tied to HPV, but Still Hesitated to Vaccinate Her Young Daughters. Here's Why She Did ItNovember 15th, 2019
  • Join now to see all

Grant Support

  • Ebv-Specific T-Cell Therapy For Nasopharynx Cancer: Immunomodulation And ResponseNational Cancer Institute2008–2009
  • Functional Mechanisms Of Antibody Inhibition Of HIV-1National Institute Of Allergy And Infectious Diseases2005–2008
  • Functional Mechanisms Of Antibody Inhibition Of HIV-1National Institute Of Allergy And Infectious Diseases2005
  • Human Monoclonal Antibodies To Study And Treat HIVNational Institute Of Allergy And Infectious Diseases2000–2003
  • Human Monoclonal Antibodies To Study And Treat HIV 1National Institute Of Allergy And Infectious Diseases1996–1998
  • Human Monoclonal Antibodies To Study And Treat HIV-1National Institute Of Allergy And Infectious Diseases1994–1995
  • Human Monoclonal Antibodies To Study And Treat HIV-1National Institute Of Allergy And Infectious Diseases1993
  • Human Monoclonal Antibodies To Study And Treat LeukemiasNational Cancer Institute1991–1992
  • HIV-1 Infection Using Human Monoclonal AntibodiesNational Institute Of Allergy And Infectious Diseases1990
  • Human Monoclonal Antibodies To Study And Treat LeukemiasNational Cancer Institute1990
  • HIV-1 Infection Using Human Monoclonal AntibodiesNational Institute Of Allergy And Infectious Diseases1988–1990
  • Human Myeloma Analogues For Making Monoclonal AntibodiesNational Cancer Institute1985–1987

Hospital Affiliations